[HTML][HTML] Next-generation TB vaccines: progress, challenges, and prospects
L Zhuang, Z Ye, L Li, L Yang, W Gong - Vaccines, 2023 - mdpi.com
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global
infectious disease and a leading cause of mortality worldwide. Currently, the only available …
infectious disease and a leading cause of mortality worldwide. Currently, the only available …
[HTML][HTML] mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
L Matarazzo, PJG Bettencourt - Frontiers in Immunology, 2023 - frontiersin.org
The success of the first licensed mRNA-based vaccines against COVID-19 has created a
widespread interest on mRNA technology for vaccinology. As expected, the number of …
widespread interest on mRNA technology for vaccinology. As expected, the number of …
Leveraging the immunoinformatics approach for designing the SARS-CoV-2 Omicron-specific antigenic cassette of mRNA vaccine
R Wadapurkar, S Singh, A Singh - Vaccine, 2024 - Elsevier
Abstract Emergence of SARS-CoV-2 Omicron variant has presented a significant challenge
to global health, demanding rapid development of mRNA-based vaccines. The mRNA …
to global health, demanding rapid development of mRNA-based vaccines. The mRNA …
[HTML][HTML] Immunogenicity of full-length and multi-epitope mRNA vaccines for M. Tuberculosis as demonstrated by the intensity of T-cell response: A comparative study …
OO Vasileva, VP Tereschenko, BN Krapivin… - Bulletin of Russian …, 2023 - cyberleninka.ru
Development of the new tuberculosis vaccines that would be effective in adults is an urgent
task: worldwide, the annual death toll of this disease exceeds 1.5 million. In the recent …
task: worldwide, the annual death toll of this disease exceeds 1.5 million. In the recent …
Development of innovative multi-epitope mRNA vaccine against Pseudomonas aeruginosa using in silico approaches
M Asadinezhad, S Khoshnood… - Briefings in …, 2024 - academic.oup.com
The rising issue of antibiotic resistance has made treating Pseudomonas aeruginosa
infections increasingly challenging. Therefore, vaccines have emerged as a viable …
infections increasingly challenging. Therefore, vaccines have emerged as a viable …
[HTML][HTML] Clinical profiles and related factors in tuberculosis patients with positive sputum smear mycobacterium tuberculosis tests
S Yu, Y Gao, J Lu, G Zhang, X Chen, R Zhang… - Scientific Reports, 2024 - nature.com
The aim of this study was to explore the related factors linked to the development and
infectivity of tuberculosis. This was achieved by comparing the clinical characteristics of …
infectivity of tuberculosis. This was achieved by comparing the clinical characteristics of …
[HTML][HTML] СРАВНИТЕЛЬНОЕ ИССЛЕДОВАНИЕ ИММУНОГЕННОСТИ ПОЛНОРАЗМЕРНОЙ И МУЛЬТИЭПИТОПНОЙ МРНК-ВАКЦИН ПРОТИВ M …
ОО Васильева, ВП Терещенко… - Вестник Российского …, 2023 - cyberleninka.ru
Разработка новых вакцин против туберкулеза, эффективных в том числе и у взрослых,
является актуальной задачей, поскольку ежегодная смертность от этого заболевания …
является актуальной задачей, поскольку ежегодная смертность от этого заболевания …